Medical experts offer a comprehensive overview of the pathophysiology of hypercortisolism, detailing its impact on β-cell dysfunction and reduced insulin sensitivity, and discuss the potential role of GLP-1 treatment in managing the condition.
Relacorilant Meets Primary Endpoint in Phase 3 GRACE Trial for Hypercortisolism
Don't Miss a Beat: Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD
Kevin Peterson, MD, MPH: Incretin Therapy's Potential
Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
Nearly 90% of US Adults Meet Cardiovascular-Kidney-Metabolic Syndrome Criteria
Presence of Diabetes Linked to Carpal Tunnel Syndrome Occurrence